🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

John F. Langenheim

ORCID: 0000-0001-8222-5286

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma”.

Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma

Cancer Research(2025)10.1158/0008-5472.can-25-0018

N/A

0.208DataRank · unranked

3 citations

G. Aaron Hobbs, Raven Davidson, Daniel Dorbin, J.J. Gómez Herrera, John F. Langenheim +22 more

Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosis

UNC Libraries(2020)10.17615/0nfp-ap14

N/A

0DataRank · unranked

0 citations

Jung‐Yoon Yoo, Bruce A. Lessey, Jae-Wook Jeong, Susan D. Ferguson, Asgerally T. Fazleabas +5 more

Co-targeting KRAS G12C and EGFR reduces both mutant and wild-type RAS-GTP

npj Precision Oncology(2022)10.1038/s41698-022-00329-w

N/A

0DataRank · unranked

19 citations

Michael Trogdon, Anita C. Guizar, John F. Langenheim, Laura Sisk-Hackworth, Edward C. Stites +1 more